Introduction
Identifying causative genes is a critical step in studying complex genetic disorders like Syndromic Congenital Heart Disease (sCHD). Copy Number Variations (CNVs) are significant contributors to sCHD, but a CNV region often encompasses multiple genes. Accurately prioritizing and pinpointing the most relevant candidate genes within these regions poses a core bioinformatics challenge. A large-scale study on a Chinese sCHD population demonstrated the foundational supporting role of the RDDC Gene Database in this crucial process. The study utilized several gene prioritization tools, including ToppGene, and explicitly noted that ToppGene's training gene set was partially derived from the RDDC Gene Database. This highlights RDDC's value as a high-quality data source, empowering downstream analysis tools and enhancing the efficiency of rare disease gene discovery.
Research Challenge: From Pathogenic CNVs to Candidate Genes
The study analyzed 109 Chinese sCHD patients using Chromosomal Microarray Analysis (CMA), identifying 29 pathogenic or likely pathogenic CNVs in 24 patients. These CNV regions collectively covered as many as 1249 protein-coding genes. Faced with such an extensive gene list, the research team needed effective strategies to narrow down the candidates most relevant to the CHD phenotype.
RDDC Gene Database Empowers Gene Prioritization
To address this challenge, the team developed a gene prioritization pipeline integrating multiple web tools and databases (including VarElect, OVA, AMELIE, and ToppGene). A key advantage of the ToppGene tool lies in the construction of its training dataset. The study specifically mentioned that ToppGene's training gene set was partially sourced from the RDDC Gene Database. The RDDC Gene Database aggregates a wealth of CHD-related gene information mined from published research and public databases.
By incorporating curated and annotated CHD-related gene data from RDDC, prioritization tools like ToppGene can learn the characteristic patterns of genes involved in heart development and disease. This enables them to more accurately assess the relevance of each gene within the CNV regions identified in this study, leading to more reliable ranking results.
Research Outcome: Pinpointing 16 Key Candidate Genes
Leveraging tools like ToppGene, which were informed by RDDC data, the research team effectively prioritized genes within the identified CNV regions. An overlap analysis across the results from four different tools ultimately pinpointed 16 candidate genes (e.g., ACVR2B, B9D1, FLCN) that were highly ranked by all methods. These genes showed high expression during mouse heart development, further supporting their potential role in cardiac development.
This case clearly illustrates that the RDDC Gene Database serves not only as an information query platform but also as a fundamental resource driving the development and application of bioinformatics analysis tools. By providing high-quality, structured rare disease gene data, RDDC effectively supports the development and training of downstream tools like ToppGene. This indirectly, yet critically, enhances the accuracy and efficiency of identifying sCHD candidate genes within complex CNV data, laying the groundwork for a deeper understanding of disease mechanisms and the development of new diagnostic targets.
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article:
Li P, Chen W, Li M, et al. Copy number variant analysis for syndromic congenital heart disease in the Chinese population. Human Genomics. 2022 Nov 2;16(1):47.
Article Link: https://pubmed.ncbi.nlm.nih.gov/36316717/
